Skip to content

Clinical trials

Recruiting Phase 1/2 Immune System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 1/2 Status: Recruiting Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20191
20202
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cabaletta Bio1
Curis, Inc.1
Lyell Immunopharma, Inc.1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Factory, Inc.1
Purespring Therapeutics Limited1
Shenzhen University General Hospital1
Thomas Advanced Medical LLC1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases9
Autoimmune Diseases4
Immunoproliferative Disorders3
Lymphoma3
Lymphoma, Non-Hodgkin3
Lymphoproliferative Disorders3
Neoplasms3
Cardiovascular Diseases2
Lymphatic Diseases2
Lymphoma, B-Cell2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.